Philips has delivered four consecutive earnings beats with an average surprise of 39.4% and free cash flow at 157% of net income, but trades below its 200-day moving average with declining revenues of -5% and a below-average quality score of 4.7.
Thesis pillars
- Earnings Beat Streak Strength↓Deteriorating
- Revenue Decline Quality Gap→Stable
- Free Cashflow Conversion→Stable
- +1 more pillar — see the Why tab for full reasoning
Koninklijke Philips N.V. NY Reg (PHG) Stock Analysis
Recovery setup
Healthcare · Medical Devices
Hold if already holding. Not a fresh buy at $27.29, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Overbought (RSI 79).
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes... Read more
Hold if already holding. Not a fresh buy at $27.29, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Overbought (RSI 79). Chart setup: Death cross but MACD improving, RSI 79. Maintain position. Not compelling to add more. Score 5.8/10, moderate confidence.
Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 79d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-08-15Recent Developments — Koninklijke Philips N.V. NY Reg
Latest news
- NEWS Koninklijke Philips NV (PHG) Shares Fall 5.7% -- GF Value Says S - GuruFocus — GuruFocus negative
- NEWS Philips (PHG) Faces Order Decline Due to North American Delays - GuruFocus — GuruFocus negative
- NEWS PHG Looks 2.7% Overvalued on GF Value™ - GuruFocus — GuruFocus neutral
- NEWS Koninklijke Philips (PHG) Expected to Announce Earnings on Tuesday - MarketBeat — MarketBeat neutral
- NEWS Philips (PHG) Secures FDA Clearance for New SpO2 Clip Sensor - GuruFocus — GuruFocus positive
Generated 2026-08-15T13:12:18Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $27.29, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Overbought (RSI 79). Chart setup: Death cross but MACD improving, RSI 79. Maintain position. Not compelling to add more. Target $28.02 (+2.7%), stop $26.11 (−4.5%), A.R:R 0.2:1. Score 5.8/10, moderate confidence.
Take-profit target: $28.02 (+2.7% upside). Target $28.02 (+2.7%), stop $26.11 (−4.5%), A.R:R 0.2:1. Stop-loss: $26.11.
Analyst target reached - limited upside remaining; Overbought (RSI 79).
Koninklijke Philips N.V. NY Reg trades at a P/E of 20.8 (forward 14.3). TrendMatrix value score: 6.8/10. Verdict: Hold.
29 analysts cover PHG with a consensus score of 3.8/5. Average price target: $32.
What does Koninklijke Philips N.V. NY Reg do?Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and...
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.